Most clinical trials investigating insulin use in MCI and AD use regular insulin analogues, so in 2015, Claxton et al. conducted a clinical trial using detemir, a long-lasting insulin analogue, to determine its effect on cognition and daily function in 60 adults with MCI or AD [33]. Here, INS is linked to Alzheimer disease.